The Züri Can study: Can regulated cannabis sales promote lower-risk cannabis use? Mini-review and study protocol

Buschner, Maximilian; Heckel, Nadine; Dürler, Patricia; Engeli, Etna J․ E; Schneider, Sophie; Havelka, Eva M; Nordt, Carlos; Herdener, Marcus

doi:10.1016/j.drugpo.2024.104610

Citations

Citation copied

Buschner, M., Heckel, N., Dürler, P., Engeli, E. J. E., Schneider, S., Havelka, E. M., Nordt, C., & Herdener, M. (2024). The Züri Can study: Can regulated cannabis sales promote lower-risk cannabis use? Mini-review and study protocol. International Journal of Drug Policy, 133, 104610. https://doi.org/10.1016/j.drugpo.2024.104610

Abstract

Background and Aims Recreational use of cannabis is illegal in most countries. Despite this, it is the third most commonly used psychoactive substance worldwide. As a result of this discrepancy, a growing number of countries have begun to reassess their legal approach to cannabis in recent years. While the health risks of cannabis and potential harm reduction measures are increasingly well understood, there are still significant gaps in knowledge about which regulatory and supply models are effective in promoting lower-risk cannabis u